Saudi Arabia Xerostomia Therapeutics Market Size & Outlook

The xerostomia therapeutics market in Saudi Arabia is expected to reach a projected revenue of US$ 12.9 million by 2030. A compound annual growth rate of 5.2% is expected of Saudi Arabia xerostomia therapeutics market from 2025 to 2030.
Revenue, 2024 (US$M)
$9.5
Forecast, 2030 (US$M)
$12.9
CAGR, 2025 - 2030
5.2%
Report Coverage
Saudi Arabia

Saudi Arabia xerostomia therapeutics market, 2018-2030 (US$M)

To keep accessing Horizon, please sign in or register for a free account

  • Access to global market statistics
  • Access to company profiles
  • Free use-cases & research insights

No credit card required*

Saudi Arabia xerostomia therapeutics market, 2018-2030 (US$M)

Saudi Arabia xerostomia therapeutics market highlights

  • The Saudi Arabia xerostomia therapeutics market generated a revenue of USD 9.5 million in 2024 and is expected to reach USD 12.9 million by 2030.
  • The Saudi Arabia market is expected to grow at a CAGR of 5.2% from 2025 to 2030.
  • In terms of segment, salivary stimulants was the largest revenue generating product in 2024.
  • Dentifrices is the most lucrative product segment registering the fastest growth during the forecast period.


Xerostomia therapeutics market data book summary

Market revenue in 2024USD 9.5 million
Market revenue in 2030USD 12.9 million
Growth rate5.2% (CAGR from 2025 to 2030)
Largest segmentSalivary stimulants
Fastest growing segmentDentifrices
Historical data2018 - 2023
Base year2024
Forecast period2025 - 2030
Quantitative unitsRevenue in USD million
Market segmentationSalivary Stimulants, Salivary Substitutes, Dentifrices
Key market players worldwideGlaxoSmithKline, Church & Dwight Co Inc, Colgate-Palmolive Co, Hikma Pharmaceuticals PLC, Pendopharm, Sun Pharmaceutical Industries, Lupin, Pfizer Inc, Parnell Pharmaceuticals Holdings Ltd, Acacia Pharma


Other key industry trends

  • In terms of revenue, Saudi Arabia accounted for 0.4% of the global xerostomia therapeutics market in 2024.
  • Country-wise, U.S. is expected to lead the global market in terms of revenue in 2030.
  • In Middle East & Africa, South Africa xerostomia therapeutics market is projected to lead the regional market in terms of revenue in 2030.
  • UAE is the fastest growing regional market in Middle East & Africa and is projected to reach USD 6.1 million by 2030.

No credit card required*

Horizon in a snapshot

  • 30K+ Global Market Reports
  • 120K+ Country Reports
  • 1.2M+ Market Statistics
  • 200K+ Company Profiles
  • Industry insights and more

Xerostomia Therapeutics Market Companies

Name Profile # Employees HQ Website

Saudi Arabia xerostomia therapeutics market outlook

The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to xerostomia therapeutics market will help companies and investors design strategic landscapes.


Salivary stimulants was the largest segment with a revenue share of 36.84% in 2024. Horizon Databook has segmented the Saudi Arabia xerostomia therapeutics market based on salivary stimulants, salivary substitutes, dentifrices covering the revenue growth of each sub-segment from 2018 to 2030.


Reasons to subscribe to Saudi Arabia xerostomia therapeutics market databook:

  • Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
  • Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
  • Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
  • Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
  • Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.

Target buyers of Saudi Arabia xerostomia therapeutics market databook

  • Our clientele includes a mix of xerostomia therapeutics market companies, investment firms, advisory firms & academic institutions.
  • 30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
  • Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
  • The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.

Horizon Databook provides a detailed overview of country-level data and insights on the Saudi Arabia xerostomia therapeutics market, including forecasts for subscribers. This country databook contains high-level insights into Saudi Arabia xerostomia therapeutics market from 2018 to 2030, including revenue numbers, major trends, and company profiles.

Partial client list

  • logo

Saudi Arabia xerostomia therapeutics market size, by product, 2018-2030 (US$M)

Saudi Arabia Xerostomia Therapeutics Market Share, 2024 & 2030 (US$M)

Saudi Arabia xerostomia therapeutics market size, by product, 2018-2030 (US$M)

Sign up - it's easy, and free!

Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our free plan indefinitely.

Explore all plans

Included in Horizon account

  • 30K+ Global Market Reports
  • 120K+ Country Reports
  • 1.2M+ Market Statistics
  • 200K+ Company Profiles
  • Industry insights and more